15 September 2022>: Clinical Research
Endobiliary Ablation Combined with Immune Nutrition Improves Quality of Life: A Preliminary Clinical Study in Patients with Advanced Malignant Obstructive Jaundice
Jie Yao 1ABE , Yalin Kong 2A* , Cheng Wang 2C , Yaping Wei 1BD , Hailian Li 1DE , Chengli Liu 23DEF*DOI: 10.12659/MSM.936863
Med Sci Monit 2022; 28:e936863
Table 2 Demographic characteristic of studied cohort.
Category | Control group (n=28) | Study group (n=31) | P value |
---|---|---|---|
52.6 (34–69) | 54.3 (33–67) | 0.714 | |
0.781 | |||
Male | 18 (64.3%) | 22 (71.0%) | |
Female | 10 (35.7%) | 9 (29.0%) | |
0.819 | |||
Pancreatic carcinoma | 12 (42.9%) | 13 (41.9%) | |
Hilar cholangiocarcinoma | 13 (46.4%) | 16 (51.6%) | |
LNM | 3 (10.7%) | 2 (6.5%) | |
0.872 | |||
Bismuth Type I* | 6 (21.4%) | 7 (22.6%) | |
Type II* | 7 (25.0%) | 8 (25.8%) | |
Type IIIa* | 7 (25.0%) | 5 (16.1%) | |
Type IIIb* | 2 (7.1%) | 3 (9.7%) | |
Common bile duct | 6 (21.4%) | 8 (25.8%) | |
9 (32.1%) | 12 (38.7%) | 0.802 | |
5 (17.9%) | 6 (19.4%) | 0.583 | |
13 (46.4%) | 15 (48.4%) | 0.556 | |
21.6 (14.5–25.1) | 21.8 (14.8–25.8) | 0.844 | |
* According to the Bismuth classification of hilar cholangiocarcinoma; LNM, lymph node metastasis; BMI. Body mass index. |